Determination of cardiac and plasma drug levels during long‐term amiodarone therapy
- 1 April 1983
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 13 (2), 123-127
- https://doi.org/10.1111/j.1365-2362.1983.tb00076.x
Abstract
A study of plasma and cardiac concentrations of amiodarone [an antiarrhythmic and antianginal agent] during the course of long-term oral therapy was made possible by the improvement of analytical high performance liquid chromatography of plasma and by human tissue extracts. The plasma level was found to increase linearly with the daily dose of the drug, above a threshold value of .apprx. 1.9 mg kg-1 day-1. The cardiac content increased linearly with the daily dose, with no threshold, showing that the drug is taken up and accumulated in the cardiac tissue, with no obvious difference between atrial and ventricular samples (P > 0.05). Both plasma and heart showed no saturation at high drug intake, a justification for increasing the oral intake in severe cases. The linear relationship between tissue and blood concentrations allows a prediction of the cardiac level from a simple and routine blood analysis.Keywords
This publication has 9 references indexed in Scilit:
- Drugs with a class III antiarrhythmic actionPharmacology & Therapeutics, 1982
- High‐Pressure Liquid Chromatography of Amiodarone in Biological FluidsJournal of Pharmaceutical Sciences, 1981
- Clinical pharmacology and therapeutic applications of the antiarrhythmic agent, amiodaroneAmerican Heart Journal, 1981
- Pharmacokinetics of amiodarone after intravenous and oral administrationEuropean Journal of Clinical Pharmacology, 1981
- Suppression of long-standing incessant ventricular tachycardia by amiodaroneJournal of Electrocardiology, 1980
- Rapid high-performance liquid chromatographic method for the measurement of amiodarone in blood plasma or serum at the concentrations attained during therapyJournal of Chromatography A, 1980
- Clinical efficacy of amiodarone as an antiarrhythmic agentThe American Journal of Cardiology, 1976
- Effects of amiodarone on thyroid function in patients with ischaemic heart disease.Heart, 1975
- Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochlorideThe American Journal of Cardiology, 1974